Xangold Lutein Qualified Health Claim Sought By Cognis
This article was originally published in The Tan Sheet
Executive Summary
Cognis Nutrition & Health is petitioning FDA for a qualified health claim linking its Xangold Natural Lutein Esters to a reduced risk of age-related macular degeneration (AMD) and cataracts
You may also be interested in...
FDA Denies Macular Degeneration Claims For Lutein, Branded Or Not
FDA extended its denial of Cognis' qualified health claim petition for Xangold branded lutein esters to other forms of the nutrient, including zeaxanthin, the agency announced in a recent communication to the ingredient supply firm
FDA Denies Macular Degeneration Claims For Lutein, Branded Or Not
FDA extended its denial of Cognis' qualified health claim petition for Xangold branded lutein esters to other forms of the nutrient, including zeaxanthin, the agency announced in a recent communication to the ingredient supply firm
FDA Denies Macular Degeneration Claims For Lutein, Branded Or Not
FDA extended its denial of Cognis' qualified health claim petition for Xangold branded lutein esters to other forms of the nutrient, including zeaxanthin, the agency announced in a recent communication to the ingredient supply firm